• Non ci sono risultati.

Hofer “Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices” Anesth

N/A
N/A
Protected

Academic year: 2021

Condividi "Hofer “Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices” Anesth"

Copied!
6
0
0

Testo completo

(1)

121

Bibliografia

1. M T. Ganter and C.K. Hofer

“Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices”

Anesth. Analg. 2008; 106:1366-1375

2. N. Salooja and D.J. Perry

“Thromboelastography”

Blood Coagulation and Fibrinolisis 2001; 12:327-337

3. D.J. McCrath, E. Cerboni, R.J. Frumento, A L. Hirsh and E. Bennett-Guerrero

“Thromboelastography Maximum Amplitude Predicts Postoperative Thrombotic Complications Including Myocardial Infarction”

Anesth. Analg. 2005; 100:1576-1583

4. E.G. Pivalizza

“TEG and Perioperative Hypercoagulability”

Anesth. Analg. 2006; 102:334-335

5. C.M. Samama

“Thromboelastography: The Next Step”

Anesth. Analg. 2001; 92:563-564

6. M.Manduca, E.F. Saporito, A. Giardina

“Tromboelastografia in terapia intensiva”

Acta Chirurgica Mediterranea, 2006; 22:145

(2)

122

7. E G. Pivalizza, P.J. Pivalizza and L.M. Weavind

“Perioperative Thromboelastography and Sonoclot Analysis in Morbidly Obese Patients”

M. Can J Anaesth 1997/44:9/pag 942-945

8. Y. Dai, A. Lee, L.A.H. Critchley and P.F. White

“Does Thromboelastography Predict Postoperative Thromboembolic Events? A Systematic Review of the Literature”

Anesth. Analg., March 1, 2009; 108(3):734-742

9. J.L. Kashuk, E.E. Moore, A. Sabel, C. Barnett, J. Haenel, T. Le, M. Pezold, J. Lawrence, W.L. Biffl, C.C. Cothren and J.L. Johnson

“Rapid Thromboelastography (r-TEG) Identifies Hypercoagulability and Predicts Thromboembolic Events in Surgical Patients”

Surgery, 2009 Oct; 146(4):764-772; discussion 772-774

10. E. Mahla, T. Lang, M.N.Vicenzi, G. Werkgartner, R. Maier, C. Probst and H. Metzler

“Thromboelastography for Monitoring Prolonged Hypercoagulability After Major Abdominal Surgery”

Anesth. Analg., 2001;92:572-577

11. O.C. Wenker, Z. Wojciechowski, R. Sheinbaum and E. Zisman

“Thromboelastography”

The International Journal of Anesthesiology, 1997: volume 1, number 3

(3)

123

12. E. Cerutti, C. Stratta, R. Romagnoli, M.M. Schellino, S. Skurzak, M. Rizzetto, G. Tamponi and M. Salizzoni

“Thromboelastogram Monitoring in the Perioperative Period of Hepatectomy for adult Living Liver Donation”

Liver Transplantation, vol 10, n 2 (February), 2004:pp 289-294

13. P. Di Benedetto, R.A. De Blasi, R. Arcioni, A. Ciaschi, L. Caberti, M. Martucci, m. Baciarello, G. Pinto

“Analisi Qualitativa della Coagulazione Tramite la Tromboelastografia”

14. Struttura e Principi dell’analizzatore TEG:Manuale d’uso TEG 5000

15. Pivalizza, Evan G. M.B.Ch.B., F.F.A.S.A.; Warters, R. David M.D

“Kaolin-activated Thromboelastography”

Anesthesiology, September 2002, vol. 97(3), pag. 758

16. V.G. Nielsen, R.T. Lyerly III and W.Q. Gurley

“The Effect of Dilution on Plasma Coagulation Kinetics Determined by Thromboelastography is Dependent on Antithrombin Activity and Mode of Activation”

Anesth. Analg., 2004; 99:1587-1592

(4)

124

17. P. Audu, V.G. Nielsen, V. Armstead, G. Powell, J. Kim, L. Kim and M. Mehta

“The Impact of Tissue Factor Pathway Inhibitor on Coagulation Kinetics Determined by Thromboelastography”

Anesth. Analg.,October 2006, vol 103, n.4, pagg.841-845

18. V.G. Nielsen, W.Q. Gurley and T.M. Burch

“The Impact ofFactor XIII on Coagulation Kinetics and Clot Strength Determined by Thromboelastography”

Anesth. Analg.,2004; 99:120-123

19. E.G. Pivalizza, D.C. Abramson and C.M. Samama

“Thromboelastography: Another Point of View”

Anesth. Analg.,2001; 93:517-518

20. K. Hopper

“Pathophysiology of Disseminated Intravascular Coagulation in Sepsi”

Crit. Care Med., 2000; 28(suppl) S9-S11

21. Società Italiana di Chirurgia dell’Obesità e delle Malattie Metaboliche (S.I.C.O.B.): linee guida e stato dell’arte della chirurgia bariatrica e metabolica in Italia.

Praiano, 19-23 Ottobre 2007

(5)

125

22. J.A. Sapala, M.H. Wood, M.P. Schuhknecht and M.A. Sapala

“Fatal Pulmonary Embolism after Bariatric Operations for Morbid Obesity: A 24-Year Retrospective Analysis”

Obesity Surgery, 2003; 13:819-825

23. J.A. Caruana, P.M. Anain and D.T. Pham

“The Pulmonary Risck Score System Reduces the Incidence and Mortality of Pulmonary Embolism after Gastric By-Pass”

Surgery, October 2009; 146(4): 678-683

24. E.E. Frezza and M.S. Wachtel

“A Aimple Venous Thromboembolism Prophylaxis Protocol for Patients Undergoing Bariatric Surgery”

Obesity, November 2006. vol.14, n.11

25. A.M.C. Macgregor

“Prophylaxis of Venous Thromboembolism in Bariatric Patients”

Obesity Surgery, 2000. 10

26. K.A. Tanaka, N.S. Key and J.H. Levy

“Blood Coagulation: Hemostasis and Thrombin Regulation”

Anesth. Analg., 2009; 108:1433-1446

27. Marco Moia

“Le novità nella profilassi del tromboembolismo venoso. Come leggere le Linee Guida ACCP 2008”

Mediamed Edizioni Scientifiche. Aprile 2009

(6)

126

28. J.P. Desborough

“The Stress Response to Trauma and Surgery”

Br J Anaesth 2000; 85:109-117

29. B.A. Rosenfeld, C. Beattie, R. Christopherson, E.J. Norris, S.M.

Frank, M.J. Breslow, P. Rock, S.D. Parker, S.O. Gottlieb, B.A.

Perler, G Melville Williams, A. Seidler and W. Bell

“The Effects of Different Anesthetic Regimens on Fibrinolysis and The Development of Postoperative Arterial Thrombosis”

Anesthesiology 1993. Vol.79, N.3. 79:435-443

Riferimenti

Documenti correlati

Vengono mostrate le curve di andamento della Tg per ogni paziente con AbTg indosabili (9 pz pannello a sinistra) e dosabili (21 pz pannello a destra), l’andamento medio

Flocs were divided into: compact particles, particles having a distinct mass concentration nucleus around which sediment crystallization networks are formed (flocks without

Despite many studies worldwide concerning methods of conducting this process, its effectiveness, and factors influencing organic substance removal, little attention is focused on

The best sedimentation was noted in variant 1 of series 1, where magnetizers were used on activated sludge bioreactor and secondary settling tank.. The application of

The representative suspension subjected to the coagulation process to determine the critical coagulation concentration was a suspension prepared from sample of Slovakian bentonite,

Table 2 Factor VIII and IX assay results (qualitative) in one-stage clotting assay according to EHL concentrate and aPTT reagent used [Adapted from Young et al., Laboratory

• When using an in vitro aPTT-based one-stage clotting assay for determining FVIII activity in patients’ blood samples, plasma FVIII activity results can be significantly affected

Objectives: to test and analyze routine coagulation test (aPTT and PT) results and their correlation with clinical and anamnestic data, to analyze the correlation